Document is current

Any future updates will be listed below

Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context

Crossref DOI link: https://doi.org/10.1136/bmjophth-2022-000983

Published Online: 2022-08-01

Published Print: 2022-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark